| 000 | 01049 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518041606.0 | ||
| 264 | 0 | _c20200812 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1540-1413 | ||
| 024 | 7 |
_a10.6004/jnccn.2019.5018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Malley, David M | |
| 245 | 0 | 0 |
_aNew Therapies for Ovarian Cancer. _h[electronic resource] |
| 260 |
_bJournal of the National Comprehensive Cancer Network : JNCCN _c05 2019 |
||
| 300 |
_a619-621 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xadverse effects |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdiagnosis |
| 773 | 0 |
_tJournal of the National Comprehensive Cancer Network : JNCCN _gvol. 17 _gno. 5.5 _gp. 619-621 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6004/jnccn.2019.5018 _zAvailable from publisher's website |
| 999 |
_c29717987 _d29717987 |
||